Hikma announces CEO change and Board appointment

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that Riad Mishlawi is stepping down as CEO and from the Board of Directors, with Executive Chairman Said Darwazah assuming CEO responsibilities immediately. Chief Financial Officer Khalid Nabilsi will join the Board and take on additional management duties. The company confirmed that group guidance for 2025 remains unchanged from its November 6th trading update, and full-year results will be reported on February 26, 2026.

Disclaimer*

UK 100

Latest directors dealings